Illumina, Inc. – LSE:0J8Z.L
Illumina stock price today
Illumina stock price monthly change
Illumina stock price quarterly change
Illumina stock price yearly change
Illumina key metrics
Market Cap | 21.36B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -8.15 |
Revenue | 4.49B |
EBITDA | 921M |
Income | -1.29B |
Revenue Q/Q | -1.01% |
Revenue Y/Y | 1.03% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 20.5% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIllumina stock price history
Illumina stock forecast
Illumina financial statements
| Jul 2023 | 1.17B | -234M | -19.9% |
|---|---|---|---|
| Oct 2023 | 1.11B | -754M | -67.38% |
| Dec 2023 | 1.12B | -176M | -15.69% |
| Mar 2024 | 1.07B | -126M | -11.71% |
| Sep 2025 | 1.24B | 104.67M | 8.4% |
|---|---|---|---|
| Oct 2025 | 1.20B | 123.27M | 10.21% |
| Dec 2025 | 1.25B | 138.88M | 11.03% |
| Mar 2026 | 1.23B | 76.85M | 6.2% |
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 11774000000 | 5.21B | 44.33% |
|---|---|---|---|
| Oct 2023 | 10122000000 | 4.22B | 41.73% |
| Dec 2023 | 10111000000 | 4.36B | 43.18% |
| Mar 2024 | 10040000000 | 4.30B | 42.89% |
| Jul 2023 | 105M | -37M | -3M |
|---|---|---|---|
| Oct 2023 | 139M | -54M | -707M |
| Dec 2023 | 223M | -85M | -26M |
| Mar 2024 | 77M | -48M | 35M |
Illumina alternative data
| Aug 2023 | 11,500 |
|---|---|
| Sep 2023 | 11,500 |
| Oct 2023 | 11,500 |
| Nov 2023 | 11,500 |
| Dec 2023 | 11,500 |
| Jan 2024 | 11,500 |
| Feb 2024 | 11,500 |
| Mar 2024 | 10,590 |
| Apr 2024 | 10,590 |
| May 2024 | 10,590 |
| Jun 2024 | 10,590 |
| Jul 2024 | 10,590 |
Illumina other data
| Insider | Compensation |
|---|---|
| Ms. Aimee L. Hoyt (1971) Chief People Officer & Senior Vice President | $864,070 |
| Mr. Sam A. Samad (1970) Chief Financial Officer & Senior Vice President | $626,700 |
| Dr. Joydeep Goswami (1971) Senior Vice President of Corporation Devel. & Strategic Planning | $384,380 |
| Dr. Alexander Aravanis M.D., Ph.D. Senior Vice President & Chief Technology Officer | |
Mr. Steve Phillpott Senior Vice President & Chief Information Officer | |
Ms. Juliet Cunningham Vice President of Investor Relations | |
| Mr. Francis A. deSouza Chief Executive Officer, Pres & Director | |
Mr. Charles E. Dadswell Senior Vice President, Gen. Counsel & Sec. | |
| Mr. Robert P. Ragusa Senior Vice President of Global Quality & Operations | |
| Ms. Karen K. McGinnis Vice President & Chief Accounting Officer |
-
What's the price of Illumina stock today?
One share of Illumina stock can currently be purchased for approximately $377.09.
-
When is Illumina's next earnings date?
Unfortunately, Illumina's (0J8Z.L) next earnings date is currently unknown.
-
Does Illumina pay dividends?
No, Illumina does not pay dividends.
-
How much money does Illumina make?
Illumina has a market capitalization of 21.36B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.49% to 4.5B US dollars.
-
What is Illumina's stock symbol?
Illumina, Inc. is traded on the LSE under the ticker symbol "0J8Z.L".
-
What is Illumina's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Illumina?
Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Illumina's key executives?
Illumina's management team includes the following people:
- Ms. Aimee L. Hoyt Chief People Officer & Senior Vice President(age: 54, pay: $864,070)
- Mr. Sam A. Samad Chief Financial Officer & Senior Vice President(age: 55, pay: $626,700)
- Dr. Joydeep Goswami Senior Vice President of Corporation Devel. & Strategic Planning(age: 54, pay: $384,380)
- Dr. Alexander Aravanis M.D., Ph.D. Senior Vice President & Chief Technology Officer
- Mr. Steve Phillpott Senior Vice President & Chief Information Officer
- Ms. Juliet Cunningham Vice President of Investor Relations
- Mr. Francis A. deSouza Chief Executive Officer, Pres & Director
- Mr. Charles E. Dadswell Senior Vice President, Gen. Counsel & Sec.
- Mr. Robert P. Ragusa Senior Vice President of Global Quality & Operations
- Ms. Karen K. McGinnis Vice President & Chief Accounting Officer
-
How many employees does Illumina have?
As Jul 2024, Illumina employs 10,590 workers.
-
When Illumina went public?
Illumina, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Illumina's official website?
The official website for Illumina is illumina.com.
-
Where are Illumina's headquarters?
Illumina is headquartered at 5200 Illumina Way, San Diego, CA.
-
How can i contact Illumina?
Illumina's mailing address is 5200 Illumina Way, San Diego, CA and company can be reached via phone at 858 202 4500.
Illumina company profile:
Illumina, Inc.
illumina.comLSE
10,590
Medical - Pharmaceuticals
Healthcare
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
San Diego, CA 92122
:
ISIN: US4523271090
:
